Verus Pharmaceuticals

13 articles about Verus Pharmaceuticals

• Verus Pharmaceuticals Announces a Lawsuit Against AstraZeneca AB and Tika Lakemedel AB

  5/28/2009

• Verus Pharmaceuticals Announces Divestiture of Pediatric GI Development Program to Meritage Pharma

  6/16/2008

• Sciele Pharma, Inc. Acquires Twinject(R) Epinephrine Auto-Injector from Verus Pharmaceuticals and Products for $29M

  3/13/2008

• Pediatric Asthma Programs Featuring PARI Pharma's eFlow Acquired by AstraZeneca PLC

  9/24/2007

• AstraZeneca PLC to Pay Up to $310 Million for Verus Pharmaceuticals' Asthma Programs

  9/24/2007

• Verus Pharmaceuticals Announces Agreement With UCB For Commercialization Of Twinject(R) In Europe

  8/21/2006

• Verus Pharmaceuticals Release: Free Epinephrine Auto-Injector Available To Anaphylaxis Sufferers

  5/24/2006

• Verus Pharmaceuticals Announces Partnership With FAAN In Honor Of Food Allergy Awareness Week (May 14-20)

  5/15/2006

• Verus Pharmaceuticals Announces Study Results Supporting The Potential Need For Two Doses Of Epinephrine To Treat Anaphylaxis

  3/7/2006

• Verus Pharmaceuticals Donates 5,000 Twinject(R) Demonstrators To Support Anaphylaxis Day At The American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting

  3/3/2006

• Verus Pharmaceuticals Appoints Tutuncu As Vice President, Medical Affairs

  1/25/2006

• Verus Pharmaceuticals Encourages Severe Allergy Sufferers To Carry Multiple Doses Of Epinephrine

  1/11/2006

• Verus Pharmaceuticals Provides Anaphylaxis And Allergy Expert To Media In Light Of Deadly Peanut Butter Kiss

  12/1/2005